Effect of HIV-related immundeficiency on pathology findings in chronic hepatitis;Influence du deficit immunitaire lie au VIH sur l'histopathologie des hepatites chroniques C

Presse Medicale

Volumn 27, Issue 32, 1998, Pages 1617-1620

  Roger, P M ^a,b   Mondain, V ^a   St Paul, M C ^a   Peyrade, F ^a   Pesce, A ^a   Fuzibet, J G ^a   Michiels, J F ^a   Dellamonica, P ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^b Hôpital de l'Archet II ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION FUNCTION; DISEASE SEVERITY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER BIOPSY; MALE; SUPERINFECTION; BIOPSY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; IMMUNOLOGY; LIVER; LYMPHOCYTE COUNT; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HEPATITIS C, CHRONIC; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; LIVER; LYMPHOCYTE COUNT; MALE; RETROSPECTIVE STUDIES;

EID: 0032564118     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Zylberberg H, Pol S. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clin Infect Dis 1996; 23:1117-25.
2. Eyster ME, Fried MW, Di bisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Blood 1994; 84: 1020-3.
3. Telfer P, Sabin C, Devereux H, Scott F, Dusheiko GM, Lee CA. The progression of HCV-associated liver disease in a cohort of haemophilic patients. Br J Haematol 1994; 87:555-61.
4. Sanchez-Quijano A, Andreu J, Gavilan F et al. Influence of human immunodeficiency virus type 1 infection on the natural course of chronic parenterally acquired hepatitis C. Eur J Clin Microbiol Infect Dis 1995; 14:949-53.
5. Soto B, Sanchez-Quijano A, Rodrigo R et al. Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis. J Hepatol 1997; 26:1-5.
6. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1:431-5.
7. Koziel MJ, Walker BD. Characteristics of the intrahepatic cytotoxic T lymphocytes response in chronic hepatits C virus infection. Springer Semin Immunopathol 1997; 19:69-83.
8. Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic-T cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Eng J Med 1997; 337:1267-74.
9. Boker KHW, Dalley G, Bahr MJ et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology 1997; 25:203-10.
10. Vento S, Cainelli F, Mirandola F et al. Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus. Lancet 1996; 347:92-3.
11. Prufer-Kramer L, Kramer A, Weigel R et al. Hepatic involvment in patients with human immunodeficiency virus infection: discrepancies between AIDS patients and those with earlier stages infection. J Infect Dis 1991; 163:866-9.
12. Sherman KE, O'Brien J, Gutierez AG et al. Quantitative evaluation of hepatitis C virus RNA in patients with concurrent human immunodeficiency virus infections. J Clin Microbiol 1993; 31:2679-82.
13. Benvegnu L, Pontisso P, Cavaletto D, Noventa F, Chemello L, Alberti A. Lack of correlation between hepatitis C virus genotype and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997; 25:211-15.
14. Poynard T, Bedossa P, Opolon P, for the OBSVIRC, METAVIR, CLINIVlR, and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997; 349:825-32.